Day One Biopharmaceuticals Other Current Assets

Day One Biopharmaceuticals (DAWN) currently reports a other current assets of $11M as of December 2025. That compares with $13M in the prior-year period — down 18.5% year over year. Use the charts on this page to explore Day One Biopharmaceuticals's other current assets history and peer comparisons.

Day One Biopharmaceuticals's other current assets decreased from $13M to $11M — a 18.5% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Day One Biopharmaceuticals reported $11M in other current assets as of December 2025. That compares with $13M in the prior-year period — down 18.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Day One Biopharmaceuticals, and consider following DAWN for alerts when major investors trade the stock.

Day One Biopharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DAWN with unrelated industries.